126 related articles for article (PubMed ID: 9873494)
1. Effects of phosphorothioate oligodeoxyribonucleotide and oligoribonucleotides on human complement and coagulation.
Kandimalla ER; Shaw DR; Agrawal S
Bioorg Med Chem Lett; 1998 Aug; 8(16):2103-8. PubMed ID: 9873494
[TBL] [Abstract][Full Text] [Related]
2. Mixed backbone antisense oligonucleotides: design, biochemical and biological properties of oligonucleotides containing 2'-5'-ribo- and 3'-5'-deoxyribonucleotide segments.
Kandimalla ER; Manning A; Zhao Q; Shaw DR; Byrn RA; Sasisekharan V; Agrawal S
Nucleic Acids Res; 1997 Jan; 25(2):370-8. PubMed ID: 9016567
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV activity of oligoribonucleotides and their phosphorothioate analogs.
Agrawal S; Tang JY; Sun D; Sarin PS; Zamecnik PC
Ann N Y Acad Sci; 1992 Oct; 660():2-10. PubMed ID: 1340121
[No Abstract] [Full Text] [Related]
4. 2'-O-methyl, 2'-O-ethyl oligoribonucleotides and phosphorothioate oligodeoxyribonucleotides as inhibitors of the in vitro U7 snRNP-dependent mRNA processing event.
Cotten M; Oberhauser B; Brunar H; Holzner A; Issakides G; Noe CR; Schaffner G; Wagner E; Birnstiel ML
Nucleic Acids Res; 1991 May; 19(10):2629-35. PubMed ID: 1710340
[TBL] [Abstract][Full Text] [Related]
5. 4'-Thio-RNA: synthesis of mixed base 4'-thio-oligoribonucleotides, nuclease resistance, and base pairing properties with complementary single and double strand.
Leydier C; Bellon L; Barascut JL; Morvan F; Rayner B; Imbach JL
Antisense Res Dev; 1995; 5(3):167-74. PubMed ID: 8785472
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys.
Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ
Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of 2'-amido-nucleosides in oligodeoxynucleotides and oligoribonucleotides as a model for 2'-linked conjugates.
Hendrix C; Devreese B; Rozenski J; van Aerschot A; De Bruyn A; Van Beeumen J; Herdewijn P
Nucleic Acids Res; 1995 Jan; 23(1):51-7. PubMed ID: 7870590
[TBL] [Abstract][Full Text] [Related]
8. Novel methods of generating specific oligonucleotide inhibitors of viral polymerases.
Chen H; Brown D; Gold L
Methods Enzymol; 1996; 275():503-20. PubMed ID: 9026656
[No Abstract] [Full Text] [Related]
9. Interaction of cationic alpha-helical peptide with phosphorothioate DNA hybrid.
Kubo T; Fujii M
Nucleic Acids Symp Ser; 1999; (42):167-8. PubMed ID: 10780432
[TBL] [Abstract][Full Text] [Related]
10. Comparative stability of eight different triple helices formed by differently modified DNA or RNA pyrimidine strands and a DNA hairpin.
Morvan F; Imbach JL; Rayner B
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):327-34. PubMed ID: 9303184
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
[TBL] [Abstract][Full Text] [Related]
12. Extending the chemistry that supports genetic information transfer in vivo: phosphorothioate DNA, phosphorothioate RNA, 2'-O-methyl RNA, and methylphosphonate DNA.
Thaler DS; Liu S; Tombline G
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1352-6. PubMed ID: 8577768
[TBL] [Abstract][Full Text] [Related]
13. Effects of synthetic oligonucleotides on human complement and coagulation.
Shaw DR; Rustagi PK; Kandimalla ER; Manning AN; Jiang Z; Agrawal S
Biochem Pharmacol; 1997 Apr; 53(8):1123-32. PubMed ID: 9175717
[TBL] [Abstract][Full Text] [Related]
14. Oligonucleotide synthesis by the use of a 2-(levulinyloxymethyl)-5-nitrobenzoyl (LMNBZ) group for the 5'-hydroxyl group of ribonucleoside and 2'-deoxyribonucleoside 3'-phosphoramidites.
Kamaike K; Takahashi H; Kakinuma T; Morohoshi K; Ishido Y
Nucleic Acids Symp Ser; 1997; (37):45-6. PubMed ID: 9585991
[TBL] [Abstract][Full Text] [Related]
15. Structural study of a DNA.RNA hybrid duplex with a chiral phosphorothioate moiety by NMR: extraction of distance and torsion angle constraints and imino proton exchange rates.
González C; Stec W; Kobylanska A; Hogrefe RI; Reynolds M; James TL
Biochemistry; 1994 Sep; 33(37):11062-72. PubMed ID: 7537083
[TBL] [Abstract][Full Text] [Related]
16. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
17. Photochemically induced RNA and DNA abasic sites.
Küpfer PA; Leumann CJ
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1177-80. PubMed ID: 18058560
[TBL] [Abstract][Full Text] [Related]
18. Chemistry and applications of oligonucleotide analogues.
Sproat BS
J Biotechnol; 1995 Jul; 41(2-3):221-38. PubMed ID: 7544590
[TBL] [Abstract][Full Text] [Related]
19. Stereocontrolled solid-phase synthesis of phosphorothioate oligoribonucleotides using 2'-O-(2-cyanoethoxymethyl)-nucleoside 3'-O-oxazaphospholidine monomers.
Nukaga Y; Yamada K; Ogata T; Oka N; Wada T
J Org Chem; 2012 Sep; 77(18):7913-22. PubMed ID: 22931131
[TBL] [Abstract][Full Text] [Related]
20. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
